Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients (RESERVE)
The Comparison of Distal Transradial Access and Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients(RESERVE Trial) A Single-center, Open, Prospective, Randomized Controlled Trial
Sponsor: Shenzhen People's Hospital
This NA trial investigates Acute ST-segment Elevation Myocardial Infarction and Distal Radial Artery Approach and is currently ongoing. Shenzhen People's Hospital leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
May 2021 — May 2023 [monthly]
Recruiting NA
First recorded
Jan 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shenzhen People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .